D.C. Mun. Regs. tit. 29, r. 29-8613
Medicaid amount, duration and scope requirements, as set forth under §1902(a)(10)(B) of the SSA, and comparability requirements, as set forth under §§1902(a)(10) and 1902(a)(17), are waived under this demonstration program to enable the DHCF to exempt beneficiaries receiving SUD treatment under this demonstration from one-dollar ($1) pharmacy cost-sharing requirements when they are receiving prescriptions associated with MAT.
There shall be no Medicaid beneficiary cost-sharing for prescriptions associated with the provision of MAT services.
Medicaid reimbursement for prescriptions associated with the provision of MAT services shall increase by the cost-sharing amount set forth in the District of Columbia Medicaid State Plan fee-for-service pharmacy services.
Effective January 1, 2020, DHCFshall increase fee-for-service pharmacy provider reimbursement rates for prescriptions associated with provision of MAT services by the cost-sharing amount identified in § 8613.3.
D.C. Mun. Regs. tit. 29, r. 29-8613